Perceptive Advisors LLC 13D and 13G filings for Travere Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 4:50 pm Sale |
2021-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Perceptive Advisors LLC | 1,845,555 3.000% |
-1,648,052![]() (-47.17%) |
Filing |
2021-02-16 3:30 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
Perceptive Advisors LLC | 3,493,607 6.800% |
3,493,607![]() (New Position) |
Filing |